Actively Recruiting
Efficacy and Duration of Pain Relief in Transforaminal and Lumbar Sympathetic Blocks
Led by Bezmialem Vakif University · Updated on 2024-06-03
20
Participants Needed
2
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Low back pain is a symptom that is frequently seen in the general population and reduces the quality of life of patients. Conventional medical treatment for patients with low back pain includes oral medication, lifestyle modification, education, exercises, lumbar traction and manual manipulation, heat application, and other interventional procedures. Epidural injections, one of the interventional procedures, are one of the common treatment methods for low back pain, especially caused by disc prolapse. Steroids are commonly used to reduce inflammation in the epidural space. Epidural steroid injection can be given to the lumbar epidural space via transforaminal, interlaminar and caudal routes, and the effectiveness rate of each is different. These interventional methods used to treat low back pain can be applied in combination. The main purpose of this study is to observe how adding lumbar sympathetic blockade will affect the patient's pain in the postoperative period in patients to whom we applied caudal epidural and transforaminal steroid injection.
CONDITIONS
Official Title
Efficacy and Duration of Pain Relief in Transforaminal and Lumbar Sympathetic Blocks
Who Can Participate
Eligibility Criteria
You may qualify if you...
- ASA physical status I, II, or III
- Patients who have undergone facet joint injection and transforaminal injection due to lumbar disc herniation
You will not qualify if you...
- Known allergies to drugs used in the treatment
- Infection near the injection site
- Known coagulation disorders
- Presence of internal fixation or severe anatomical changes like scoliosis or tumor
- History of sympathetic chemical or thermal neurolysis
- Alcohol or drug use
- Disorder of consciousness
- Liver failure, renal failure, or advanced heart failure
- Uncontrolled diabetes mellitus
- Morbid obesity (BMI greater than 35 kg/m2)
- Pregnant or breastfeeding women
- Not willing to give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Aylin Ceren Şanlı
Istanbul, Turkey (Türkiye)
Actively Recruiting
2
Aylin Ceren
Istanbul, Turkey (Türkiye)
Completed
Research Team
Z
Zübeyde Özdemir
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here